Related Experiment Video
Updated: Jan 8, 2026

05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
20.3K
Key Attributes of a Reusable Insulin Pen Injector That Balances Optimal Insulin Delivery With Sustainability
Anya Sonia Wernersson1, Shahid Akhtar1, Kasper Bayer Frøhling2
1Novo Nordisk A/S, Søborg, Denmark.
Journal of Diabetes Science and Technology
|December 16, 2025
Summary
New reusable insulin pen injectors offer a sustainable solution to diabetes management. These devices aim to reduce the environmental impact of insulin delivery, addressing concerns about plastic waste and carbon footprint.
Area of Science:
- Endocrinology and Metabolism
- Materials Science and Engineering
- Environmental Science
Background:
- The global prevalence of diabetes is increasing, driving demand for insulin therapies.
- Insulin pen injectors are widely used for subcutaneous insulin delivery due to convenience and accuracy.
- Current disposable plastic insulin pens contribute significantly to medical waste and environmental pollution.
Purpose of the Study:
- To describe the technical attributes of the DuraTouch (DT) reusable insulin pen injector.
- To compare DT with other Novo Nordisk insulin pen injectors.
- To illustrate how DT can meet user needs while reducing environmental burden.
Main Methods:
- Technical specifications of the DuraTouch (DT) reusable insulin pen injector.
- Comparative analysis with NovoPen 4 (NP4) and FlexTouch insulin pen injectors.
- Evaluation of functional attributes for user needs and environmental impact.
Main Results:
- DuraTouch (DT) is a reusable insulin pen injector designed for durability and ease of use.
- DT offers a potentially more sustainable alternative to disposable plastic insulin pens.
- The design aims to balance user functionality with reduced environmental impact.
Conclusions:
- Reusable insulin pen injectors like DuraTouch (DT) are crucial for sustainable diabetes management.
- DT addresses the environmental concerns associated with disposable insulin delivery devices.
- Further adoption of durable, reusable insulin pens can mitigate the ecological footprint of diabetes care.
More Related Videos
Related Concept Videos
Insulin Formulations: Types and Delivery
605
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
605
Insulin: Dosing Regimen and Adverse Effects
656
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
656
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K

